Adenoviruses with an RGD-4C modification of the fiber knob elicit a neutralizing antibody response but continue to allow enhanced gene delivery

This publication has 27 references indexed in Scilit:

• Serum and Ascites Neutralizing Antibodies in Ovarian Cancer Patients Treated with Intraperitoneal Adenoviral Gene Therapy
  Human Gene Therapy, 2002
• Assessment of Adenoviral Vector Safety and Toxicity: Report of the National Institutes of Health Recombinant DNA Advisory Committee
  Human Gene Therapy, 2002
• Human Gene Therapy Protocols (Complete Updated Listing)
  Human Gene Therapy, 2001
• An Adenovirus with Enhanced Infectivity Mediates Molecular Chemotherapy of Ovarian Cancer Cells and Allows Imaging of Gene Expression
  Molecular Therapy, 2001
• Pseudopackaging of Adenovirus Type 5 Genomes into Capsids Containing the Hexon Proteins of Adenovirus Serotypes B, D, or E
  Journal of Virology, 2001
• Targeting adenovirus
  Gene Therapy, 2000
• Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration
  Gene Therapy, 1999
• Adenoviral Gene Therapy Leads to Rapid Induction of Multiple Chemokines and Acute Neutrophil-Dependent Hepatic Injury in Vivo
  Human Gene Therapy, 1999
• Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressingα₁-Antitrypsin after Systemic Delivery
  Human Gene Therapy, 1998
• Humoral immune response to the capsid components of recombinant adenoviruses: Routes of immunization modulate virus‐induced Ig subclass shifts
  European Journal of Immunology, 1997